HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $522,208 | -3.2% | 14,129 | 0.0% | 0.01% | -6.7% |
| Q3 2023 | $539,728 | +23.1% | 14,129 | +16.2% | 0.02% | +36.4% |
| Q2 2023 | $438,431 | -8.6% | 12,155 | -3.2% | 0.01% | -15.4% |
| Q1 2023 | $479,552 | +341.7% | 12,557 | +558.1% | 0.01% | +333.3% |
| Q4 2022 | $108,565 | +35.7% | 1,908 | -5.6% | 0.00% | 0.0% |
| Q3 2022 | $80,000 | -81.3% | 2,022 | -79.2% | 0.00% | -75.0% |
| Q2 2022 | $428,000 | – | 9,736 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |